Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Glycosides Stories

2010-02-04 13:02:00

XI'AN, China, Feb. 4 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced preliminary 2009 results and provided guidance for 2010. Huifeng Bio-Pharmaceutical Technology anticipates revenues between $13 million to $14 million for the full year ended December 31, 2009. This...

2010-01-11 08:00:00

ASUNCION, Paraguay, Jan. 11 /PRNewswire/ -- On January 7th, PureCircle South America SA (PCSA) and the Cooperativa Colonias Unidas signed a contract for the production and supply of stevia leaves. The event was held at the Cooperative headquarters in Obligado and attended by managers and executives from both companies. Both PCSA and the Cooperative are forging a strong commitment to develop the production of proprietary varieties of high-quality stevia, to meet the growing international...

2010-01-07 06:00:00

PRINCETON, N.J., Jan. 7 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer. Treatment with Myocet(TM) has already shown a reduced level of cardiotoxicity as compared to...

2009-12-08 00:30:00

NEW ORLEANS, Dec. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals....

739066839e06178e351155745429e3ec
2009-11-01 14:52:39

Going smaller could bring better results, especially when it comes to cancer-fighting drugs. Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment. After delivering the drug to the tumor, the delivery vehicle breaks down into harmless byproducts, markedly decreasing the toxicity for the...

2009-10-29 10:45:00

OAK BROOK, Ill., Oct. 29 /PRNewswire/ -- PureCircle (LSE: PURE), the world's leading producer of natural high-intensity sweeteners, including Reb A, is pleased to announce the launch of Revive Supplement Water(TM) in New Zealand by Frucor. It is the country's first low-calorie vitamin-enhanced beverage to feature a pure stevia all-natural sweetener. The Revive Supplement Water is sweetened naturally by PureCircle's high-purity Reb A. PureCircle VP Sales Asia Pacific, Chris Hession, said:...

2009-10-12 06:00:00

OAK BROOK, Ill., Oct 12 /PRNewswire/ -- In recognition of the significant commercial and social development opportunities that stevia cultivation and extraction offer regional development, Paraguay Vende, the economic growth program of the United States Agency for International Development (USAID) in conjunction with the government of Paraguay, have signed a cooperation and mutual investment agreement with global stevia firm, PureCircle, to promote the cultivation of stevia in the south...

2009-09-25 05:09:03

Study points way to precisely targeted cancer treatments UC Irvine researchers have created a new approach that vastly improves the targeting of chemotherapeutic drugs to specific cells and organs. Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent...

2009-09-10 16:27:00

HORSHAM, Pa., Sept. 10 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for DOXIL (doxorubicin HCI liposome injection) in combination with docetaxel for the treatment of women with locally advanced and metastatic breast cancer. Centocor Ortho Biotech is evaluating the FDA's letter and will respond to the agency as quickly...

2009-07-15 16:22:00

HORSHAM, Pa., July 15 /PRNewswire/ -- Based on the data presented today, the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended that the combination of DOXIL(R) (doxorubicin HCI liposome injection) and docetaxel did not provide a sufficient benefit-risk profile for the treatment of women with locally advanced or metastatic breast cancer. Women with locally advanced and metastatic breast cancer who have received prior anthracycline treatment...


Latest Glycosides Reference Libraries

45_20138aaa34c0aef5a2af87b137102229
2009-04-23 11:07:34

Bittercress (Barbarea vulgaris), also commonly known as Herb Barbara, Rocketcress, Yellow Rocketcress, Winter Rocket, and Wound Rocket, is a European biennial herb. This plant displays a rosette of shiny, dark green leaves at the base and additional pinnately divided leaves on the stem. In the spring, yellow flowers originate in tightly packed terminal groups just above the foliage. Bittercress grows wildly as a weed in many parts of North America. The flowers can be in bloom May...

More Articles (1 articles) »